Leica Biosystems logo — Advancing Cancer Diagnostics 
Improving Lives

Leica Biosystems

Advancing Cancer Diagnostics Improving Lives

Founded 1989 Germany Germany 2454 employees Series Undisclosed Biotechnology, Education +2

General Information

Company Name Leica Biosystems
Founded Year 1989
Location Germany Germany +11
Employees 2454
Industries Biotechnology, Education, Health Care +1
Funding Stage Series Undisclosed
Social

Get notified when Leica Biosystems moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Leica Biosystems

Leica Biosystems, founded in 1989 and headquartered in Germany, is a prominent player in the Biotechnology, Education, Health Care, and Manufacturing industries. The company's slogan, "Advancing Cancer Diagnostics, Improving Lives," reflects its commitment to making a positive impact on society through innovative solutions. In September 2024, Leica Biosystems secured a significant €10.00M Series Undisclosed investment from Cherry Ventures, Speedinvest, and SquareOne. Being part of Danaher, Leica Biosystems benefits from its science and technology leadership, enabling the company to offer unparalleled expertise and solutions to its customers. This strategic partnership allows Leica Biosystems to leverage cutting-edge science and technology to improve the lives of billions across the globe. The company's focus on advancing cancer diagnostics aligns with the growing need for innovative solutions in the health care sector. Moreover, it's worth noting that Leica Biosystems' Privacy Policy emphasizes the importance of data protection and user-generated content regulation. The company's commitment to ethical practices and respect for data privacy is evident in its stringent policies. In conclusion, Leica Biosystems' recent undisclosed investment and its collaboration with industry-leading investors position it to further advance its mission of improving cancer diagnostics and contributing to the broader healthcare landscape.

Taxonomy: Cancer Diagnostics, Anatomic Pathology, Laboratory Workflow Solutions, Digital Pathology, Histopathology, Neuropathology, Histology, Pathology, Histology Sample Preparation, IHC & ISH Advanced Staining, Routine & Special Staining, Consumables, Microtomy

No funding data available for Leica Biosystems yet.

Get notified when Leica Biosystems raises funding

Leica Biosystems Alternatives & Competitors

Leica Biosystems vs

Advancing care, test by test, everywhere

379 employees
Biotechnology, Health Care
Leica Biosystems vs

Banking made easy on purpose. Member FDIC

Debt Financing
319 employees
Crypto, Finance
Leica Biosystems vs
Payoneer
Payoneer United States

The financial technology company empowering the world’s SMBs to transact, do business, and grow glob...

Unknown
3135 employees
B2B, Finance

FAQ About Leica Biosystems

Advancing Cancer Diagnostics Improving Lives
Leica Biosystems was founded in 1989.
Leica Biosystems is headquartered in Germany.
Leica Biosystems operates in the following industries: Biotechnology, Education, Health Care, Manufacturing.
Leica Biosystems has approximately 2454 employees.
Top alternatives and competitors to Leica Biosystems include HemoCue AB, F&M, a Lawrence Bank, Payoneer, Shoreline Wealth Advisors, Don Marsh Agency, Inc . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Leica Biosystems and HemoCue AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Leica Biosystems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy